Join us for a free webinar covering the latest information for patients and caregivers:
We invite you to learn more about:
- How your non-Hodgkin lymphoma (NHL) subtype influences your treatment plan
- Current and emerging therapies for aggressive lymphomas
- Managing side effects of treatment
- The benefit of discussing quality-of-life concerns with your healthcare team
Mark Roschewski, MD
CDR, Commissioned Corps, Public Health Service
Lymphoid Malignancies Branch, Center for Cancer Research
National Cancer Institute, National Institutes of Health
Ask Dr. Roschewski a question during the Q&A session.
Support for this program provided by Genentech & Biogen, Pharmacyclics & Janssen, and The Leukemia & Lymphoma Society.